Digital Health Startups

Blueprint Genetics is a genetic testing company that combines laboratory science, genetics, and bioinformatics to analyze and interpret genetic data. It operates as a global company with in-house software, cloud, and bioinformatics teams supporting its testing services.

4 investors

Botco.ai builds generative AI agents using a Retrieval-Augmented Generation framework to automate tasks such as adverse event reporting, patient referrals, clinical support, and CRM workflows. It serves organizations in healthcare, behavioral health, pharma, provider engagement, and government/citizen services.

4 investors

BrainSightAI develops AI-based neuroimaging products that analyze MRI data to provide evidence-based treatment guidance for neurosurgeons, psychiatrists, and neurologists, along with a digital aid for patients. The company works in brain mapping and connectivity at the intersection of neuroscience and machine learning, serving hospitals and clinical teams.

4 investors

BRAINBox Solutions develops a multi-modality diagnostic approach for mild traumatic brain injury (mTBI), combining blood biomarker panels with tablet-based neurocognitive testing to produce an objective injury score and a prognosis of post-injury symptoms. The tools are aimed at clinicians for diagnosing concussion and predicting patient outcomes.

4 investors

BrainSpec develops software for analyzing and visualizing MR spectroscopy (MRS) neuroimaging data, aiming to make a non-invasive "virtual biopsy" available to clinicians and researchers. Its technology targets patient populations with conditions such as brain tumors, Alzheimer's disease, and Multiple Sclerosis.

4 investors

Breakthru offers a library of 2-minute guided movement and breathing microbreaks designed to reduce stress and musculoskeletal pain while improving focus, energy, and cognitive endurance. It is a workplace wellness product for teams and organizations, using microbreaks during meetings, trainings, and team challenges.

4 investors

BreatheSuite delivers pulmonary rehabilitation for COPD patients in a home-based format, combining physical therapy and respiratory therapy led by licensed clinicians. The service provides personalized care plans designed to improve breathing, strength, and overall well-being, accepting Medicare and major insurance coverage.

4 investors

Budgie is a healthcare benefits platform that uses a data model to match employees to the most cost-effective health plan during open enrollment and helps them lower fees or get reimbursed on prescriptions and medical visits year-round. It serves employers and their employees in the US, giving HR teams analytics on which benefits matter to their workforce.

4 investors

C2i Genomics develops a whole-genome sequencing platform that uses AI algorithms to build patient-specific cancer signatures for detecting minimal residual disease (MRD) and monitoring cancer. It serves oncology and cancer diagnostics use cases.

4 investors

Candoo Tech provides technology support and training services designed for older adults, helping them use devices, software applications, and smart home technology safely and effectively. The company serves seniors and their adult children or caregivers who need assistance with technology adoption and ongoing support.

4 investors

Candor Health builds an AI-native provider data intelligence platform for payers, digital health companies, and provider groups, supporting care navigation, referral management, network strategy, and regulatory compliance. It focuses on making healthcare provider data accurate and accessible for healthcare organizations.

4 investors

Capsulomics offers Esopredict, a DNA methylation-based risk-stratification test that predicts progression from Barrett's esophagus to high-grade dysplasia or esophageal adenocarcinoma for gastroenterologists and pathologists. The test is used as a secondary option when the company's primary TissueCypher spatialomics test cannot provide results.

4 investors

Cardiac Insight develops ECG-based cardiac diagnostic products, including software using international consensus criteria, to help clinicians detect and screen for cardiac conditions such as sudden cardiac death risk in athletes. The company serves physicians and clinical settings in the cardiology and sports cardiology space, and is a subsidiary of Dreamtech.

4 investors

CardioSignal develops digital cardiac biomarkers using motion sensors in smartphones to detect heart disease without additional devices, targeting patients and primary care systems globally. The technology replaces invasive and costly standard diagnostic methods to enable faster and more accessible cardiovascular care.

4 investors

Cardurion is a cardiovascular disease-focused company developing therapeutics, with a pipeline advanced through clinical development, trial design, regulatory affairs, and commercialization. It draws on a board of cardiovascular disease experts and industry veterans to guide its drug development.

4 investors

Carebox builds AI-driven clinical trial matching technology (Carebox Connect) that indexes trial eligibility criteria to match patients' clinical and genomic profiles with relevant studies. It serves pharma trial sponsors, hospital research centers, and patient advocacy groups for trial recruitment and referral, as well as patients and physicians searching for treatment options.

4 investors

CarePredict offers a platform that detects patterns in the daily activities of older adults to signal health changes and enable early intervention. It serves senior living operators and communities with data and tools to support resident well-being, staff efficiency, and proactive personalized care.

4 investors

Caretaker Medical develops wireless medical devices for non-invasive continuous hemodynamic monitoring using patented Pulse Decomposition Analysis technology. The company serves clinical and military healthcare environments with devices designed to assess vital signs such as blood pressure, heart rate, and shock status.

4 investors

Cascador Health provides real-world data analytics and clinical research services to pharmaceutical companies and healthcare organizations, focusing on market access, clinical evidence generation, and therapy adoption in healthcare. The company specializes in respiratory medicine and offers market sizing, epidemiological studies, health economics assessments, outcome measurement, and patient/physician engagement services.

4 investors

Caspar develops a privacy-first Physical AI platform that processes continuous real-world data to help healthcare care teams intervene earlier and deliver proactive care at scale, particularly for vulnerable populations.

4 investors

Castor developed decision-support software that analyzed CAD files to help manufacturers decide between additive manufacturing and traditional production, offering cost and lead-time comparisons.

4 investors

CCX offers a platform for managing access agreement activities, with a focus on collaboration between payers and pharmaceutical companies. It serves the healthcare and pharmaceutical market.

4 investors

Cenegenics is a physician-led age management and performance health system that uses diagnostics and data-driven interventions to help individuals optimize strength, cognition, metabolic health, and longevity. The company serves individuals seeking personalized, medically grounded approaches to extending peak physical and cognitive performance.

4 investors

Centauri provides data-driven technology and services for U.S. health plans and health systems, turning fragmented clinical data into analytics used for risk adjustment, care coordination, quality optimization, and clinical data exchange. Its solutions target healthcare reimbursement across Medicare, Medicaid, Commercial, and Exchange programs to improve payment accuracy and member outcomes.

4 investors